All relevant data are within the paper.

Introduction {#sec005}
============

Cataract and glaucoma are the top two causes of blindness in the world respectively and they frequently co-exist in the same eye \[[@pone.0118852.ref001]\]. In 2010, World Health Organization estimated that cataract is responsible for 51% of world blindness, representing about 20 million people (World Health Organization 2010), while another 4.5 million and 3.9 million people are blind due to open-angle and angle-closure glaucoma respectively \[[@pone.0118852.ref002]\]. In Singapore, about 1.14% and 0.5% of the population are affected by primary angle-closure glaucoma (PACG) and primary open angle glaucoma (POAG) respectively \[[@pone.0118852.ref003]\].

Treatment for patients with concurrent cataract and glaucoma includes sequential surgery and combined phacotrabeculectomy \[[@pone.0118852.ref004]\]. Combined phacotrabeculectomy has its advantages. First, it reduces risks of additional intra-ocular surgeries, because frequently after trabeculectomy, there is rapid progression of lens opacities into visually significant cataracts that require cataract surgery \[[@pone.0118852.ref005]\]. Secondly, sequential cataract surgery is associated with increased risk of trabeculectomy failure which may be minimised by combined phacotrabeulectomy \[[@pone.0118852.ref006]\]. Tan et al had previously determined that trabeculectomy with or without antimetabolites had low complications rates in Asian eyes at 1 year, with prolonged hypotony and bleb leak being the commonest complications \[[@pone.0118852.ref007]\]. However, longer-term data for combined phacotrabeculectomy with intraoperative Mitomycin C (MMC) is still lacking \[[@pone.0118852.ref008]\]. The effect of postoperative complications on phacotrabeculectomy success rates is also unclear. To address these gaps, we aimed to document the intraoperative and postoperative complications of combined phacotrabeculectomy with MMC in a multi-ethnic Asian population, and evaluate the impact of postoperative complications on surgical outcome.

Materials and Methods {#sec006}
=====================

This was a retrospective review of 262 consecutive eyes of patients who had undergone primary phacotrabeculectomy with intraoperative MMC at National University Hospital (NUH) in Singapore between 1^st^ January 2008 and 31^st^ December 2010 (36-months period). The inclusion criteria for our study were as follows: Diagnosed with primary open angle glaucoma or primary angle closure glaucomaDiagnosed with visually-significant cataract on slit-lamp examinationNo previous surgical or laser operation on eye except laser peripheral iridotomyIntraocular pressure (IOP) measured with either Goldmann applanation tonometry or TonoPenHave ≥ 3 IOPs recorded before operation, measured on separate visitsCompleted at least one year of follow-up duration postoperatively

For those who underwent surgery for both eyes, only the first eye was included, consistent with the method used by similar previous studies \[[@pone.0118852.ref007], [@pone.0118852.ref009]\]. The study was conducted in accordance with the tenets of the World Medical Association's Declaration of Helsinki and had ethics approval from the National Healthcare Group Domain Specific Review Board (NHG-DSRB), with waiver of informed consent. Patient information was anonymized and de-identified prior to analysis.

Glaucoma is defined as the presence of characteristic optic disc changes (thinning, excavation or focal notch of the neurosensory rim, or asymmetrical cupping between the eyes of \> 0.2) and intraocular pressure (IOP) ≥ 21 mmHg on one or more visits preoperatively by Goldman applanation tonometry (GAT) with characteristic visual field changes compatible with glaucoma, defined as follows \[[@pone.0118852.ref010]\]: Glaucoma Hemifield test outside normal limits, and≥ 3 contiguous points on the pattern deviation plot depressed at P \< 5% level.

In addition, PACG was defined as glaucoma in which ≥ 180° of the posterior trabecular meshwork was not visible on non-indentation gonioscopy, with or without peripheral anterior synechiae \[[@pone.0118852.ref007]\].

Data collection {#sec007}
---------------

Each medical record was reviewed and relevant data was transferred to a standardized form which included patient demographic information, type of glaucoma (POAG or PACG), relevant systemic conditions and intraoperative details. Preoperative and postoperative data were collected for best-corrected visual acuity (BCVA), IOP, as well as number and duration of glaucoma medication usage.

Postoperative complications were stratified into early (≤ 1 month), late (\> 1 month), or recurrent (occurring more than once after surgery) \[[@pone.0118852.ref011]\]. A complication was considered severe if it required reoperation or resulted in a loss of BCVA by ≥ 2 lines on Snellen chart. Hypotony was defined as IOP \< 6 mmHg on one or more occasions after surgery, and considered prolonged if it persisted for more than or equal to two weeks \[[@pone.0118852.ref011]\]. Shallow anterior chamber (AC) was defined as irido-corneal contact extending to within 1 mm of the pupil \[[@pone.0118852.ref011]\]. Hyphema was defined as microscopic or macroscopic blood in anterior chamber and/or iris. Bleb leak was defined as either a positive Siedel's test or visible conjunctival leak from leak after surgery. All above definitions, as well as definitions for other less common complications, were also included in accordance with Guidelines on Design and Reporting of Glaucoma Surgical Trials \[[@pone.0118852.ref011]\].

Surgical Procedures {#sec008}
-------------------

All the patients underwent a standard operation performed by trained ophthalmologists, which comprised the following steps: Peri-bulbar or topical anaesthesiaFornix-based conjunctival flap in the superior nasal or temporal quadrantCreation of a 4 x 3 mm rectangular partial-thickness scleral flap with adequate hemostasisSponges soaked in 0.4 mg/ml (0.4%) MMC inserted in the subconjunctival pocket for 5 minutes.Sponges removed and 0.4% MMC flushed out using 20 ml of balanced saline solution.Phacoemulsification of cataract and acrylic intraocular lens implantationSclerostomy creation with straight beaver blade assisted by Kelly\'s punchSurgical peripheral iridectomyScleral flap closure with 10-O nylon sutures until there was a slow egress of aqueousConjunctival closure with 8-O vicryl sutures

After surgery, all patients were discharged with antibiotic and steroid eye drops from three-hourly to four times a day for the first week after surgery. Antibiotic eye drops were stopped one month from surgery date. Steroid eye drops were continued for up to six months with slow taper depending on the bleb morphology, IOP and AC depth as assessed by an experienced glaucoma consultant. In general, after an uncomplicated surgery, patients were reviewed at approximately one day, one week, one month, three months and every six months thereafter.

Primary and Secondary Outcome Measures {#sec009}
--------------------------------------

The primary outcome measure was the cumulative occurrence of postoperative complications at 3-years for all patients after combined phacotrabeculectomy with MMC. All complications occurring after 3-years were censored. Secondary outcome measures included risk factors for the commonest postoperative complications, correlation between postoperative complications and failure, incidence of intraoperative complications, and number of reoperations required. Time to failure was defined as the time from surgical treatment to time to 1) loss of visual acuity to no light perception, or 2) first of two consecutive follow-up visits after one month in which the patient had persistent IOP \< 6mmHg or greater than stipulated upper limit (15 mmHg, 18 mmHg and 21 mmHg), or 3) reoperation for glaucoma, whichever occurred first.

Statistical Analysis {#sec010}
--------------------

Statistical analysis was performed using SPSS 21.0 (SPSS Inc, Chicago, Illinois). For categorical variables, Pearson's chi-square test or Fisher's exact test was performed. For continuous variables, an independent t-test was performed for normally-distributed samples, while a corresponding non-parametric test was used for non-normally distributed samples. Multivariate logistics regression (including demographic information, preoperative IOP and type of glaucoma) was performed for the top three commonest complications. Kaplan Meier survival analysis was performed for the time to hypotony, hyphema, shallow AC, as well as time to failure. A p value of less than 0.05 was considered statistically significant.

Results {#sec011}
=======

Baseline characteristics {#sec012}
------------------------

A total of 262 total operations were performed between January 2008 and December 2010. Of these, 67 (25.6%) were excluded due to the following reasons: postoperative follow-up duration of less than one year (*n* = 32, 12.2%), preoperative IOP taken on less than three occasions (*n* = 16, 6.1%), previous intraocular operation/lasers except peripheral iridotomy performed such as laser trabeculoplasty, iridoplasty, retinal detachment surgery, pterygium surgery (*n* = 14, 5.3%), secondary glaucoma such as traumatic, neovascular, uveitic glaucoma (*n* = 5, 1.9%). 195 eyes of 168 patients fulfilled inclusion criteria. A total of 160 first operated eyes were included in the final analysis (eight eyes were excluded due to intra-operative phacoemulsification-related complications).

Baseline characteristics of patients were summarized in **[Table 1](#pone.0118852.t001){ref-type="table"}**. PACG patients had significantly higher proportion of females (p = 0.01) and higher mean preoperative IOP (p \< 0.001). Otherwise, the other demographic characteristics were similar between patients with POAG and PACG.

10.1371/journal.pone.0118852.t001

###### Baseline characteristics of patients with primary open angle glaucoma and primary angle closure glaucoma.
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  **Characteristics[\*](#t001fn002){ref-type="table-fn"}**                                 **All eyes (*n* = 160)**   **POAG eyes (*n* = 105)**   **PACG eyes (*n* = 55)**   **p-value[^‡^](#t001fn004){ref-type="table-fn"}**
  ---------------------------------------------------------------------------------------- -------------------------- --------------------------- -------------------------- ---------------------------------------------------
  **Patient demographic information**                                                                                                                                        
  **Mean age, years (SD)**                                                                 68.2 (8.2)                 68.2 (8.0)                  68.1 (8.6)                 0.93
  **Gender (female), n (%)**                                                               72 (45.0)                  39 (37.1)                   33 (60.0)                  0.01
  **Race, n (%)** [^§^](#t001fn005){ref-type="table-fn"}                                                                                                                     
  **Chinese**                                                                              121 (75.6)                 77 (73.3)                   44 (80.0)                  0.35
  **Malay**                                                                                13 (8.1)                   7 (6.7)                     6 (10.9)                   
  **Indian**                                                                               13 (8.1)                   10 (9.5)                    3 (5.5)                    
  **Other Asians**                                                                         13 (8.1)                   11 (10.5)                   2 (3.6)                    
  **Diabetes mellitus**                                                                    60 (37.5)                  43 (41.0)                   17 (30.9)                  0.21
  **Ocular characteristics**                                                                                                                                                 
  **Left eye, n (%)**                                                                      73 (45.6)                  48 (45.7)                   25 (45.5)                  0.98
  **Preoperative IOP, mmHg (SD)**                                                          17.2 (3.5)                 16.4 (3.2)                  18.6 (3.6)                 \< 0.001
  **CDR (SD)**                                                                             0.65 (0.19)                0.66 (0.18)                 0.64 (0.20)                0.42
  **Pre-operative BCVA, median LogMAR (IQR)** [^**†**^](#t001fn003){ref-type="table-fn"}   0.301 (0.176--0.398)       0.301 (0.176--0.398)        0.301 (0.176--0.398)       0.30
  **Intra-ocular pressure lowering medications**                                                                                                                             
  **Number of medications, n (SD)**                                                        1.6 (0.9)                  1.6 (0.9)                   1.7 (1.0)                  0.55
  **Mean duration of medication, months (SD)**                                             44.1 (38.4)                47.1 (40.4)                 38.5 (33.9)                0.18

CDR = cup-disc ratio; IOP = intraocular pressure; IQR = interquartile range; LogMAR = logarithm of the minimum angle of resolution; PACG = primary angle closure glaucoma; POAG = primary open angle glaucoma; SD = standard deviation.

\*Data presented as mean (standard deviation) or number (percentage), unless otherwise specified.

^†^Data presented as median (interquartile range).

^‡^p-values were calculated using chi-square test, independent t-test or Mann-Whitney U test as appropriate.

^§^p-value for race was calculated using Chinese and non-Chinese as categorical variables (chi-square test).

Intraoperative complications {#sec013}
----------------------------

Ten patients (6.0%) experienced intraoperative complications. Of these, eight (4.8%) were phacoemulsification related (posterior capsular rupture \[PCR\]: *n* = 7, 4.2%; incomplete capsulorrhexis: *n* = 1, 0.6%), while two cases (1.2%) were trabeculectomy-related (conjunctival button hole: *n* = 1, 0.6%; full thickness scleral defect during scleral flap creation: *n* = 1, 0.6%). PCRs were treated intraoperatively with vitrectomy and sulcus placement of IOL, while an extracapsular cataract extraction was performed for the patient with incomplete capsulorrhexis.

Postoperative complications {#sec014}
---------------------------

The mean follow-up duration ± standard deviation (SD) was 47 ± 14 months for all patients. No eye lost light perception during the duration of follow-up. 69 patients (43.1%) experienced at least one complication in the postoperative period. Of a total of 95 postoperative complications, most occurred within and resolved within the first month (*n* = 73, 76.8%). The top three commonest complications were hypotony (*n* = 41, 25.6%), hyphema and shallow AC (both *n* = 16, 10.0%). Of those with hypotony, the mean IOP was 13.1 ± 3.8 mmHg at 3 years postoperatively, as compared to a mean IOP of 14.9 ± 3.8 mmHg for those without hypotony (p = 0.049; number loss to follow up = 26, 16.3%). Seven patients (4.2%) experienced prolonged hypotony. A summary of postoperative complications was shown in **[Table 2](#pone.0118852.t002){ref-type="table"}**. There was no significant difference in incidence of complications between POAG and PACG patients (POAG: *n* = 40, 38.1%; PACG: *n* = 29, 52.7%; p = 0.08). Six patients (3.8%) had severe complications that included shallow AC, hyphema, persistent inflammation more than three months, lens malposition, with five patients (3.1%) requiring reoperation. The patient with persistent inflammation also had worsening of BCVA by ≥ 2 Snellen lines. There was no significant difference in the incidence of severe complications between POAG and PACG patients (POAG: *n* = 2, 1.9%; PACG: *n* = 4, 7.3%; p = 0.18, Fisher's Exact Test).

10.1371/journal.pone.0118852.t002

###### Summary of all postoperative complications up to and including 3 years after surgery.
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  **Complication[\*](#t002fn002){ref-type="table-fn"}**   **Early (*n* = 73)**   **Late (*n* = 13)**   **Early and late (*n* = 9)**   **Total (*n* = 95)**
  ------------------------------------------------------- ---------------------- --------------------- ------------------------------ ----------------------
  **Hypotony**                                            31 (42.4)              5 (38.5)              5 (55.6)                       41 (43.2)
  **Hyphema**                                             16 (21.9)              0                     0                              16 (16.8)
  **Shallow AC**                                          13 (17.8)              2 (15.4)              1 (11.1)                       16 (16.8)
  **Bleb leak**                                           5 (6.8))               0                     0                              5 (5.3)
  **Choroidal detachment**                                3 (4.1)                1 (7.7)               0                              4 (4.2)
  **Blebitis**                                            0                      2 (15.4)              0                              2 (2.1)
  **Persistent inflammation**                             0                      0                     2 (22.2)                       2 (2.1)
  **PVD/Macular hole**                                    2 (2.7)                0                     0                              2 (2.1)
  **Aqueous misdirection syndrome**                       1 (1.4)                0                     0                              1 (1.1)
  **Dellen**                                              0                      1 (7.7)               0                              1 (1.1)
  **Descemet membrane detachment**                        0                      1 (7.7)               0                              1 (1.1)
  **Lens malposition**                                    1 (1.4)                0                     0                              1 (1.1)
  **Recurrent uveitis**                                   0                      0                     1 (11.1)                       1 (1.1)
  **Stitch granuloma**                                    0                      1 (7.7)               0                              1 (1.1)
  **Tenon cyst**                                          1 (1.4)                0                     0                              1 (1.1)
  **Endophthalmitis**                                     0                      0                     0                              0

AC = anterior chamber; early = less than or equal to one month from operation; early and late = occurring at least once in each; late = more than one month from operation; PVD = posterior vitreous detachment.

\*Data presented as number (percentage).

After adjusting for age, type of glaucoma (POAG versus PACG) and mean preoperative IOP, our results showed that male gender and non-Chinese race were independent risk factors for developing shallow AC after phacotrabeculectomy (male: odds ratio \[OR\] = 9.56, 95% confidence interval \[95% CI\] 1.84--49.67, p = 0.01; Chinese: OR 0.20, 95% CI 0.04--0.92, p = 0.04, **[Table 3](#pone.0118852.t003){ref-type="table"}**). However, further subgroup analysis showed that neither race nor gender was a significant risk factor for developing shallow AC with concomitant hypotony (p ≥ 0.05 for both).

10.1371/journal.pone.0118852.t003

###### Logistic regression analysis of the risk factors for hypotony, hyphema and shallow anterior chamber[\*](#t003fn002){ref-type="table-fn"}.
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                                                                  **Hypotony**        **Hyphema**   **Shallow AC**                                   
  --------------------------------------------------------------- ------------------- ------------- -------------------- ------ -------------------- -------
  **Age**                                                         1.03 (0.99, 1.08)   0.18          1.00 (0.94, 1.06)    0.92   0.98 (0.91, 1.04)    0.46
  **Gender**                                                                                                                                         
    **Male**                                                      0.97 (0.46, 2.05)   0.93          3.20 (0.92, 11.2)    0.07   9.56 (1.84, 49.67)   0.01
    **Female**                                                    Reference           Reference     Reference                                        
  **Race**                                                                                                                                           
    **Chinese**                                                   0.73 (0.21, 2.59)   0.73          1.40 (0.16, 11.99)   0.77   0.20 (0.04, 0.92)    0.04
    **Malay**                                                     0.58 (0.10, 3.51)   0.55          5.33 (0.43, 65.57)   0.19   0.17 (0.01, 2.20)    0.18
    **Other Asians** [^**†**^](#t003fn003){ref-type="table-fn"}   0.97 (0.18, 5.24)   0.97          1.34 (0.07, 25.28)   0.85   \< 0.001             0.998
    **Indians**                                                   Reference           Reference     Reference                                        
  **Type of glaucoma**                                                                                                                               
    **PACG**                                                      1.49 (0.67, 3.32)   0.33          1.65 (0.50, 5.42)    0.41   2.76 (0.82 9.33)     0.10
    **POAG**                                                      Reference           Reference     Reference                                        
  **Preop IOP**                                                   1.03 (0.92, 1.15)   0.64          0.94 (0.79, 1.12)    0.48   1.11 (0.93, 1.33)    0.25

AC = anterior chamber; CI = confidence interval; IOP = intraocular pressure; OR = odds ratio; PACG = primary angle closure glaucoma; POAG = primary open angle glaucoma; preop = preoperative.

\*Hypotony, hyphema and shallow AC were the top three commonest complications (in descending order).

^†^Other Asians excluding Chinese, Malays and Indians.

Postoperative complications and success rates {#sec015}
---------------------------------------------

Kaplan-Meier survival analysis was performed for the success rates of combined phacotrabeculectomy at 21 mmHg, 18 mmHg and 15 mmHg respectively, and stratified according to the occurrence of hypotony postoperatively (**[Fig. 1](#pone.0118852.g001){ref-type="fig"}, [Fig. 2](#pone.0118852.g002){ref-type="fig"}, [Fig. 3](#pone.0118852.g003){ref-type="fig"}**). The 3-year cumulative incidence of failure (standard error \[SE\]) for 21 mmHg, 18 mmHg and 15 mmHg were 10.8% (2.5%), 18.5% (3.1%) and 45.9% (4.1%) respectively. Hypotony was associated with significantly higher risk of failure at 21 mmHg (cumulative percent (SE): with hypotony: 25.3% (7.0%); without hypotony: 5.9% (2.2%), p \< 0.001), but not at 18 mmHg and 15 mmHg (p = 0.09 and p = 0.88 respectively). There was no difference between the cumulative incidence of failure (SE) between POAG and PACG eyes for 21 mmHg (cumulative percent (SE): POAG: 10.7% (0.03%); PACG: 11.1% (0.04%), p = 0.92), and for other definitions of failure (p \> 0.05 for both). After adjusting for age, gender, race, preoperative IOP and type of glaucoma, our results showed that among factors influencing hypotony, hypotony with another simultaneous complication was an independent risk factor for failure at 21 mmHg, while both early and late hypotony were also significantly associated with failure (**[Table 4](#pone.0118852.t004){ref-type="table"}**).

![Kaplan Meier survival analysis of eyes with and without post-operative hypotony achieving surgical success (21mmHg).\
Failure was defined as loss of visual acuity to no light perception, or first of 2 consecutive follow-up visits after 1 month in which the patient had persistent intraocular pressure (IOP) \< 6mmHg or \> 21mmHg, or reoperation for glaucoma, whichever occurs first.](pone.0118852.g001){#pone.0118852.g001}

![Kaplan Meier survival analysis of eyes with and without post-operative hypotony achieving surgical success (18mmHg).\
Failure was defined as loss of visual acuity to no light perception, or first of 2 consecutive follow-up visits after 1 month in which the patient had persistent intraocular pressure (IOP) \< 6mmHg or \> 18mmHg, or reoperation for glaucoma, whichever occurs first.](pone.0118852.g002){#pone.0118852.g002}

![Kaplan Meier survival analysis of eyes with and without post-operative hypotony achieving surgical success (15mmHg).\
Failure was defined as loss of visual acuity to no light perception, or first of 2 consecutive follow-up visits after 1 month in which the patient had persistent intraocular pressure (IOP) \< 6mmHg or \> 15mmHg, or reoperation for glaucoma, whichever occurs first.](pone.0118852.g003){#pone.0118852.g003}

10.1371/journal.pone.0118852.t004

###### Cox proportional hazard analysis for hypotony as a risk factor for surgical failure (Intraocular pressure \> 21 mmHg).
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  **Hypotony risk factors[\*](#t004fn002){ref-type="table-fn"}**                            **Multivariable**   
  ----------------------------------------------------------------------------------------- ------------------- -------
  **Onset of hypotony**                                                                                         
       **Early hypotony**                                                                   5.1 (1.6, 16.2)     0.01
       **Late hypotony**                                                                    10.4 (1.6, 67.1)    0.01
       **No hypotony**                                                                      Reference           
  **Type of complications**                                                                                     
       **Hypotony only**                                                                    4.5 (1.2, 16.3)     0.02
       **Hypotony with other complication(s)** [^**†**^](#t004fn003){ref-type="table-fn"}   8.1 (2.4, 27.7)     0.001
       **Other complications(s)**                                                           Reference           

CI = confidence interval; HR = hazard ratio; early hypotony = hypotony occurring less than or equal to 30 days postoperatively; late hypotony = hypotony occurring later than 30 days postoperatively.

\*Each model was adjusted independently for age, gender, race, type of glaucoma and mean preoperative intraocular pressures.

^†^Other complication(s) include: bleb leak, blebitis, choroidal detachment, choroidal effusion, descemet membrane detachment, hyphema, lens malposition, persistent inflammation shallow anterior chamber.

Reoperations {#sec016}
------------

18 patients (11.3%) required at least one surgical intervention postoperatively. The most commonly performed procedure was bleb needling with antimetabolite use (*n* = 7, 4.4%). Other trabeculectomy-related surgical interventions performed include glaucoma drainage device insertion (n = 2, 1.3%), AC reformation (*n* = 2, 1.3%), AC washout, bleb refashioning and irrigation and aspiration of hyphema (*n* = 1, 0.6% each). Two phacoemulsification-related interventions were performed: lens repositioning and soft lens matter removal (*n* = 1, 0.6% each). Other postoperative surgical procedures included the following: stitch granuloma removal, trans pars plana vitrectomy, laser peripheral iridotomy and conjunctival defect repair (*n* = 1, 0.6% each).

Discussion {#sec017}
==========

Combined phacotrabeculectomy with MMC is a commonly performed surgery on patients with concurrent cataract and glaucoma. In our study, the commonest postoperative complications up to three years were hypotony, hyphema and shallow AC respectively. There was a trend showing that PACG eyes had a higher complication rate as compared to POAG, although the difference was not statistically significant (p = 0.08). Most complications were self-limiting and did not necessitate further surgical intervention. The majority (77%) of postoperative complications occurred within the first month only, suggesting that the first postoperative month is the most important period for postoperative monitoring.

Similarly, the Trabeculectomy Outcomes Group Audit Study Group also emphasized the importance of intensive proactive postoperative care to reduce rates of surgical complication after trabeculectomy. In their audit of 428 eyes of 395 white patients with open-angle glaucoma, 183 out of 184 (99%) suture manipulations and 21 out of 22 (95%) of resuturings took place in the first three months, and they proceeded to recommend that close follow-up of patients and proactive intervention are necessary after trabeculectomy, though they did not specify strict duration \[[@pone.0118852.ref012]\].

Several other authors have also reported complication rates after trabeculectomy or phacotrabeculectomy \[[@pone.0118852.ref007], [@pone.0118852.ref009], [@pone.0118852.ref013]\]. A recent large retrospective case series of postoperative complications after phacotrabeculectomy in Asian eyes reported prolonged hypotony (defined as IOP \< 5mmHg) as the commonest complication (*n* = 14, 1.5%), followed by gross hyphema (*n* = 6, 0.6%), and bleb leak (*n* = 4, 0.4%) respectively \[[@pone.0118852.ref007]\]. Our higher rates of hypotony could be due to a more inclusive definition of hypotony being used (IOP \< 6 mmHg, occurring any time postoperatively), the inclusion of patients with intraoperative MMC use only, which has a known association with prolonged hypotony \[[@pone.0118852.ref014]\], and the longer follow-up period. The incidence of hypotony as a postoperative complication varies greatly between different studies, ranging from as low as 1.5% (Tan et al. 2011) to 38% (Murthy et al. 2006). This is in part due to the non-standardized definitions of hypotony and surgical techniques including the use of different anti-metabolites. In our study, we followed the recommended guidelines for hypotony reporting according to the Guidelines on Design and Reporting of Glaucoma Surgical Trials, stratified by time of onset and severity accordingly. It is interesting to note that though one-quarter of our patients experienced hypotony postoperatively, none required reoperation or experienced significant visual loss of ≥ 2 Snellen lines, suggesting that most transient early postoperative hypotony could be safely managed conservatively if the AC is not flat and hypotony is not prolonged.

To our knowledge, no study has established a correlation between a specific complication and success rates in combined phacotrabeculectomy. Our study has shown that occurrence of early postoperative hypotony was associated with higher risk of drainage failure (IOP \> 21 mmHg). Specifically, our study has found that hypotony occurring with other complication(s) simultaneously significantly increased the risk of surgical failure at IOP \> 21 mmHg, while both early and late hypotony were associated with higher risk of surgical failure at IOP \> 21 mmHg. Benson et al suggested that early hypotony could result in the breakdown of the blood-aqueous barrier, resulting in the release of inflammatory mediators, where persistent conjunctival inflammation could then induce enhanced bleb scarring \[[@pone.0118852.ref015]\]. In Asian population where the propensity for bleb scarring is greater than in White population, this phenomenon could be amplified and result in poorer surgical outcomes \[[@pone.0118852.ref016]\]. Prolonged early hypotony could also influence bleb maturation, inhibit the formation of multiform wall reflectivity and microcysts with multiple layers in the crucial first postoperative month. These early bleb morphological features are shown to be predictive of bleb function and surgical success up to six months postoperatively \[[@pone.0118852.ref017]\]. This could lead to earlier formation of bleb scarring despite adequate MMC application, which may obstruct further outflow of aqueous humor. Hypotony, when accompanied by other complications such as shallow AC and bleb leak, may also hasten the process of bleb scarring and result in higher risk of failure.

In our study, we were unable to identify any risk factors associated with postoperative hypotony. Phacoemulsification has been demonstrated to have a modest sustained reduction in IOP for both patients with POAG and PACG eyes \[[@pone.0118852.ref018], [@pone.0118852.ref019], [@pone.0118852.ref020]\]. Previous studies have also reported a rapid and transient decline of IOP after phacotrabeculectomy up to 20% incidence of hypotony postoperatively \[[@pone.0118852.ref021]--[@pone.0118852.ref023]\]. Concurrent phacoemulsification and trabeculectomy also appear to have an additive effect in IOP reduction, which could predispose patients into postoperative hypotony \[[@pone.0118852.ref024], [@pone.0118852.ref025]\]. Nonetheless, Shingleton et al proposed certain modifications in surgical technique which could reduce postoperative hypotony from 20% to as low as 6.1%, such as 1) using a more posterior keratome entry during phacoemulsification to incorporate the limbal vascular arcade and conjunctiva, 2) using measured phacoemulsification incision length of 2.5 mm instead of estimated length of 2.0 mm, and 3) aiming for a higher case-completion IOP of 20 mmHg \[[@pone.0118852.ref022]\]. In our study, the majority of eyes with hypotony occurred early postoperatively which subsequently resolved with many achieving IOP in the low teens (mean 13.1 ± 3.8 mmHg at 3 years after surgery). This suggests that the surgeon factor also plays an important role in determining the early post-operative IOP, which includes the tension of sutures, number of sutures, immediate IOP at the end of surgery and timing of suturelysis \[[@pone.0118852.ref026]--[@pone.0118852.ref028]\].

Interestingly, our study also found that male patients and being non-Chinese were independent risk factors for developing postoperative shallow AC (**[Table 3](#pone.0118852.t003){ref-type="table"}**). In view of the large variance in 95% CI for both readings, however, this study may be inadequately powered for the above assertions. Budenz et al have reported black race as a strong predictor for failure after phacotrabeculectomy \[[@pone.0118852.ref029]\], though there is no corresponding study which demonstrated any racial or gender predisposition for developing a postoperative complication. More studies would be necessary to evaluate possible racial and gender differences, including the possibility of different cultural and behavioural practices, which may influence aqueous outflow and bleb maturation in the early postoperative period. Notwithstanding, it could be helpful to emphasize the importance of wound care in the postoperative period and remind all patients to avoid applying forceful pressure on the eye.

We recognize the limitations of this study. Being a retrospective study, it was impossible to standardize documentation and the complication rates may have been underreported. For example, we were unable to acquire the full data on corneal endothelial cell count in our patients before and after phacotrabeculectomy, as a reduction of corneal endothelial cell count has been reported and could compromise the safety profile of this operation \[[@pone.0118852.ref030], [@pone.0118852.ref031]\]. Multiple surgeons were in charge of the pre-, intra- and postoperative care of different patients and this could confound documentation errors and introduce systemic biases. We tried to minimize this by conducting a standardized audit with an independent observer who is not employed under NUH department. The low incidence of certain complications also could have introduced greater statistical uncertainty due to random error, or resulted in a lack of statistical power to detect if less frequent complications (e.g. persistent inflammation) were risk factors for failure. Loss to follow-up was another issue as 22% of our patients (*n* = 35) were lost to follow-up within the first three years. We hypothesize that these patients could have defaulted follow-up because they were most likely asymptomatic following the surgery (we noted four patients passed away in the postoperative period). A follow-up duration of three years also appears insufficient to determine the true incidence of blebitis. Longer prospective studies or randomized controlled trials would be preferred to address the above limitations, and at the same time to clearly and better define the advantages of combined phacotrabeculectomy with intraoperative MMC over other therapeutic options for glaucoma in this population.

In conclusion, our study showed that the majority of complications from phacotrabeculectomy with MMC were transient and self-limiting, with hypotony, hyphema and shallow anterior chamber being the most common. Patients could be reassured of the safety of this operation; however, close and active monitoring is critical, especially in the early postoperative period, to prevent the occurrence of prolonged hypotony or multiple complications which may result in surgical failure.
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